GLP-1 medications like Ozempic, Wegovy, and Zepbound have become some of the most talked-about treatments for weight loss, but their benefits may extend far beyond the scale.
In this episode, Diana breaks down what GLP-1 medications are, how they work in the body, and what current research shows about kidney health. She explores the growing evidence for kidney protection, discusses emerging research in autosomal dominant polycystic kidney disease (ADPKD), and shares practical considerations for people with PKD who are considering semaglutide or tirzepatide medications.
Podden och tillhörande omslagsbild på den här sidan tillhör
Diana Bruen MS, RD. Innehållet i podden är skapat av Diana Bruen MS, RD och inte av,
eller tillsammans med, Poddtoppen.
